Institutional response to FDA warning on aprotinin and impact on outcomes

INTRODUCTION: New evidence of potential risks of aprotinin in 2006 generated public concern about a previously approved drug that was routinely used. In response, we assembled a team of experts within the institution to form guidelines for the appropriate use of aprotinin in cardiac surgery. We repo...

Descripción completa

Detalles Bibliográficos
Autores principales: Swaminathan, M, Stuart, M, Hughes, G C, Jaggers, J, Hill, S E, Milano, C A, Bennett-Guerrero, E, Stafford-Smith, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: EDIMES Edizioni Internazionali Srl 2009
Materias:
Research-Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484539/
https://www.ncbi.nlm.nih.gov/pubmed/23439283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484539/
https://www.ncbi.nlm.nih.gov/pubmed/23439283

Ejemplares similares